A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder
Clinical trial NCT02919579 · COMPLETED
Trial details
- NCT number
- NCT02919579
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-07
- Primary completion
- 2018-06-29
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.